Racing Medication And Testing Consortium

News, Articles, Videos and other content about Racing Medication And Testing Consortium

Confidentiality in Research Called Necessary

An official with the RMTC said confidentiality agreements used when the organization considers research to set thresholds and withdrawal times for medications are necessary because of scientific factors.

RMTC Board Approves Model Rule on Penalties

The Racing Medication and Testing Consortium said July 19 its board of directors has approved a model rule on multiple violation penalties and forwarded the suggested change to racing commissioners for consideration.

Writing Award Prize Benefits RMTC

Writing Award Prize Benefits RMTC

The $25,000 prize intended for three New York Times writers will instead benefit drug testing programs. The newspaper's editorial ethics policy prohibits the writers from accepting the award.

RMTC Board Names Interim Director

At its April 23 meeting the Racing Medication and Testing Consortium board of directors approved an agreement with The Jockey Club to engage the full-time services of Jamie Haydon as RMTC interim executive director.

No Salix in Graded Stakes for 2YOs in 2012

No Salix in Graded Stakes for 2YOs in 2012

The American Graded Stakes Committee said Aug. 10 it will employ a pilot program that will ban race-day medications -- primarily the anti-bleeding drug Salix -- in graded 2-year-old stakes in 2012.

Officials Confirm International Drug Summit

As expected the Racing Medication and Testing Consortium board of directors said April 20 it will join the National Thoroughbred Racing Association and American Association of Equine Practitioners in organizing a drug summit.

International Drug Summit Said to Be Planned

International Drug Summit Said to Be Planned

Industry organizations including the National Thoroughbred Racing Association will propose an international summit on equine medication this year in the wake of calls for the race-day ban of anti-bleeding drugs.

Sources: Waterman Leaving Post at RMTC

Dr. Scot Waterman, executive director of the Racing Medication and Testing Consortium for almost 10 years, is leaving the post at the end of April, according to multiple industry sources.

RCI: Phase Out Use of Drugs in Five Years

RCI: Phase Out Use of Drugs in Five Years

In an announcement that could meet with disagreement with some horsemen's groups and perhaps others, the Association of Racing Commissioners International has called for a five-year phase-out of equine medication in racing.

RMTC Acts to Reduce Potential Impact of Bute

The Racing Medication and Testing Consortium has lowered the testing threshold level for phenylbutazone, a commonly used non-steroidal anti-inflammatory drug, but has kept the administration time at 24 hours prior to a race.

Possible Change in Drug Rules Questioned

The Association of Racing Commissioners International is looking at extending the cutoff time for use of non-steroidal anti-inflammatory drugs in racehorses beyond 24 hours prior to a race, but horsemen's groups claim the action is premature.

Horsemen, Chemist: Drug Problem Exaggerated

The National Horsemen's Benevolent and Protective Association said July 1 it plans to be more involved as the racing industry considers medication and drug-testing policies horsemen believe could be detrimental and counterproductive.

International Drug Coalition Meets Recently

The International Federation of Horse Racing Authorities Advisory Council on Prohibited Substances and representatives of the Racing Medication and Testing Consortium recently met in Lexington during the 75th convention of the Association of Racing Commissioners International and were sponsored by The Jockey Club.

Changes Ahead for Drug-Testing Protocol

The Racing Medication and Testing Consortium is developing protocol designed to streamline and improve equine drug-testing in the United States. And it is taking a few pages from a 1991 study that didn't gain any traction in the racing industry when it was released.

Most Popular Stories